| 1 July 2010 | Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease.
| Thambisetty, M; Simmons, A; Velayudhan, L; et al. |
| 10 January 2013 | A blood gene expression marker of early Alzheimer's disease.
| Lunnon, Katie; Sattlecker, M; Furney, SJ; et al. |
| 6 February 2014 | Cross-region reduction in 5-hydroxymethylcytosine in Alzheimer's disease brain.
| Condliffe, Daniel; Wong, A; Troakes, C; et al. |
| 15 June 2012 | Functional annotation of the human brain methylome identifies tissue-specific epigenetic variation across brain and blood
| Davies, Matthew N.; Volta, M; Pidsley, R; et al. |
| 10 June 2013 | Inflammatory proteins in plasma are associated with severity of Alzheimer's disease.
| Leung, R; Proitsi, P; Simmons, A; et al. |
| 17 August 2014 | Methylomic profiling implicates cortical deregulation of ANK1 in Alzheimer's disease
| Lunnon, Katie; Smith, Rebecca; Hannon, E; et al. |
| 25 February 2012 | Mitochondrial dysfunction and immune activation are detectable in early Alzheimer's disease blood
| Lunnon, Katie; Ibrahim, Z; Proitsi, P; et al. |
| 15 October 2015 | A Pathway Based Classification Method for Analyzing Gene Expression for Alzheimer's Disease Diagnosis.
| Voyle, N; Keohane, A; Newhouse, S; et al. |
| 24 September 2012 | Plasma based markers of [11C] PiB-PET brain amyloid burden.
| Kiddle, SJ; Thambisetty, M; Simmons, A; et al. |
| 1 November 2014 | Plasma proteins predict conversion to dementia from prodromal disease.
| Hye, A; Riddoch-Contreras, J; Baird, AL; et al. |
